Skip to main content
ECAT
NYSE Unknown

Activist Investor Saba Capital Reduces Stake by $14.97 Million in BlackRock ESG Term Trust

Arie Shkolnikov · Analysis by Wiseek AI
Sentiment info
Negative
Importance info
7
Price
$14.75
Mkt Cap
0
52W Low
$13.36
52W High
$17.14
52W Position info
10% above low
Off High info
14% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

ECAT is trading near its 52-week low of $13.36 (10% above the low).

Summary

Saba Capital Management, an activist investor, has reduced its stake in BlackRock ESG Capital Allocation Term Trust by selling approximately $14.97 million worth of shares, lowering its ownership from an implied 22.57% to 21.49%.


Key Events · Ownership and Investor Activity · ECAT

  • Significant Share Sales by Activist Investor

    Saba Capital Management sold 1,071,366 shares of common stock between March 25, 2026, and April 24, 2026, for a total value of approximately $14.97 million.

  • Reduced Ownership Stake

    The sales reduced Saba Capital's beneficial ownership from an implied 22.57% to 21.49% of the outstanding common shares.

  • Ongoing Activist Involvement

    This amendment follows previous 13D filings and occurs amidst recent DEFA14A filings, suggesting continued activist engagement or a potential shift in strategy by Saba Capital.


Analysis · ECAT · Unknown

This Schedule 13D/A filing indicates that Saba Capital Management, a known activist investor, has continued to reduce its position in BlackRock ESG Capital Allocation Term Trust. The sale of over 1 million shares, totaling approximately $14.97 million, represents a notable reduction in their stake. While Saba Capital remains a significant shareholder with 21.49% ownership, the consistent selling by an activist investor could signal a shift in their investment thesis or a move to reallocate capital. Investors should monitor future filings for further changes in Saba Capital's position, especially given the ongoing proxy contest indicated by recent DEFA14A filings.

At the time of this filing, ECAT was trading at $14.75 on NYSE in the Unknown sector. The 52-week trading range was $13.36 to $17.14. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ECAT - Latest Insights

ECAT
Jun 29, 2026, 6:04 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $15.51
Real-time Price: $15.14 info
Change: -$0.3713 (-2%) info
Market Cap: N/A info
ECAT
Jun 03, 2026, 5:01 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $15.29
Real-time Price: $15.14 info
Change: -$0.145 (-0.95%) info
Market Cap: N/A info
ECAT
Jun 02, 2026, 4:21 PM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $15.81
Real-time Price: $15.14 info
Change: -$0.670 (-4%) info
Market Cap: N/A info
ECAT
Jun 01, 2026, 4:22 PM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $15.79
Real-time Price: $15.14 info
Change: -$0.650 (-4%) info
Market Cap: N/A info
ECAT
May 21, 2026, 5:00 PM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $15.23
Real-time Price: $15.14 info
Change: -$0.090 (-0.59%) info
Market Cap: N/A info